NEW
YORK, Jan. 16, 2025 /PRNewswire/ -- The global
vitamin D testing market size is estimated to grow by
USD 182.6 million from 2024 to 2028,
according to Technavio. The market is estimated to grow at a CAGR
of over 4.96% during the forecast period.
For comprehensive forecast and historic data on regions,market
segments, customer landscape, and companies- Click for the snapshot
of this report
Report
Attribute
|
Details
|
Base Year
|
2023
|
Forecast
period
|
2024-2028
|
Historic Data
for
|
2018 - 2022
|
Segments
Covered
|
Product
(25-hydroxyvitamin D testing and 1 25-dihydroxyvitamin D testing),
End-user (Diagnostic laboratories, Hospitals and physician clinics,
and Home care settings), Geography (North America, Europe, Asia,
and Rest of World (ROW)), Technology (), and Indication
()
|
Key Companies
Covered
|
Abbott, Danaher, F.
Hoffmann-La Roche Ltd, Siemens, Quest Diagnostics Incorporated,
bioMérieux SA, DiaSorin S.p.A., Thermo Fisher Scientific Inc.,
Beckman Coulter, Inc. (BD), Tosoh Bioscience, Inc., Biohit Oyj,
BioVendor Laboratorni medicina AS, Boditech Med Inc., DiaSys
Diagnostic Systems GmbH, Everly Health Inc., Laboratory Corp. of
America Holdings, Qualigen Therapeutics Inc., Quidelortho Corp.,
Randox Laboratories Ltd., Recipe Chemicals and Instruments
GmbH.
|
Regions
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Region Outlook
- North America
- Europe
- Asia
- Rest of World
1. North America - North America is estimated to
contribute 35%. To the growth of the global market. The
Vitamin D Testing Market report forecasts market growth by revenue
at global, regional & country levels from 2017 to
2027.
The North American region dominated the global vitamin D testing
market in 2023, accounting for the largest share. The US, in
particular, led this segment due to the presence of numerous
vendors such as Abbott, Danaher, and Quest Diagnostics Inc. (Quest
Diagnostics). These companies provide a wide range of vitamin D
testing products, including Abbott's ARCHITECT 25-OH Vitamin D
assay, which is a chemiluminescent microparticle immunoassay (CMIA)
used for quantitative measurement of 25-hydroxyvitamin D in human
plasma and serum, enabling assessment of vitamin D sufficiency.
For more insights on North
America's significant contribution along with the market
share of rest of the regions and countries - Download a
FREE Sample
Segmentation Overview
- Product
- 1.1 25-hydroxyvitamin D testing
- 1.2 1 25-dihydroxyvitamin D testing
- End-user
- 2.1 Diagnostic laboratories
- 2.2 Hospitals and physician clinics
- 2.3 Home care settings
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
- Country
US, Germany, China, UK, and Canada
- Technology
- Indication
1.1 Fastest growing segment:
The 25-hydroxyvitamin D segment dominated the global vitamin D
testing market in 2022, accounting for the largest share. This is
due to the importance of 25-hydroxyvitamin D in indicating vitamin
D levels in the body. Vitamin D is essential for various bodily
functions, including modulation of cell growth, neuromuscular and
immune function, and reduction of inflammation. The two forms of
vitamin D, D2 and D3, are converted into 25-hydroxyvitamin D in the
liver before being further metabolized into the active form,
1,25-hydroxyvitamin D, in the kidney. A deficiency of
25-hydroxyvitamin D is defined as less than 12ng/mL by the
Institute of Medicine. A simple blood test can determine the levels
of 25-hydroxyvitamin D, which is crucial for diagnosing conditions
like osteoporosis and rickets, and monitoring individuals at risk
of deficiency, such as the elderly, obese, and those with limited
sunlight exposure. The market is driven by the rising prevalence of
these conditions, particularly among children. Vendors like
DiaSorin offer advanced solutions, such as the LIAISON 25 OH
Vitamin D TOTAL Assay, for reliable and quick determination of
vitamin D status.
Get a glance at the market contribution of rest of the segments
- Download a FREE Sample Report in minutes!
Research Analysis
Vitamin D is a crucial nutrient for maintaining strong bones and
teeth by regulating the absorption of Calcium and Phosphate from
the diet. Deficiency in Vitamin D can lead to bone disorders such
as Osteoporosis and Rickets. Abnormal levels of Vitamin D can be
detected through various laboratory tests, including
Radioimmunoassay and HPLC. Hospitals and Diagnostic Laboratories
are significant contributors to Vitamin D testing, while home care
settings are also gaining popularity. Reimbursement policies vary,
and sedentary lifestyles and limited sunlight exposure increase the
risk of Vitamin D deficiency. Nutrition issues, medical conditions,
and organ damage can also cause abnormal levels of Vitamin D in the
blood. Phosphorus and other minerals, such as Magnesium and
Tissues, also play essential roles in bone health and may be
affected by Vitamin D deficiency. Awareness campaigns are crucial
to promote Vitamin D testing and prevent the health complications
associated with deficiency.
Market Overview
Vitamin D, a vital nutrient for strong bones and teeth, plays a
crucial role in calcium absorption and immune system regulation.
Deficiencies in Vitamin D can lead to bone disorders such as
osteoporosis and rickets, as well as nutrient deficiencies, organ
damage, and medical conditions like osteomalacia, weakness,
fatigue, muscle aches, and muscle twitching. Abnormal levels of
Vitamin D can be detected through various tests, including
Radioimmunoassay and HPLC, in hospitals, diagnostic laboratories,
home care settings, and standalone clinical laboratories. Factors
contributing to Vitamin D deficiency include sedentary lifestyles,
lack of sunlight exposure, and nutrition issues. Reimbursement
policies and awareness campaigns are essential for early diagnosis
and treatment. Vitamin D is a fat-soluble steroid prohormone with a
long half-life, found in plasma serum and tissues. Vitamin D
testing is crucial for populations at risk, including infants,
children, the elderly, pregnant women, and those with bone changes,
fractures, or developmental delay. Health organizations and
healthcare authorities are promoting preventive healthcare through
diagnostic tests and new market initiatives, expanding the global
presence and production capacities of Vitamin D testing.
Start exploring market insights by Download a FREE
Sample Report in minutes!
Key Topics Covered:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Venodr Landscape
11 Vendor Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vitamin-d-testing-market--35-of-growth-to-originate-from-north-america-technavio-302353153.html
SOURCE Technavio